Skip to content
10-Q

Quarterly Report

10x Genomics, Inc. TXG

0001770787-25-000032

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities Q1 2025 · Mar 31, 2025 $107.9M
Current Liabilities Q1 2025 · Dec 31, 2024 $117.63M
Total Liabilities Q1 2025 · Mar 31, 2025 $196.5M
Total Liabilities Q1 2025 · Dec 31, 2024 $208.5M
Current Assets Q1 2025 · Mar 31, 2025 $579.73M
Current Assets Q1 2025 · Dec 31, 2024 $584.39M
Total Assets Q1 2025 · Mar 31, 2025 $903.39M
Total Assets Q1 2025 · Dec 31, 2024 $918.64M
Shares Diluted Q1 2025 · Mar 31, 2024 119.39M sh
Capex Q1 2025 · Mar 31, 2024 $2.91M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$15.73M
Stockholders Equity Q1 2025 · Mar 31, 2024 $718.83M
Stockholders Equity Q1 2025 · Dec 31, 2023 $741.04M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.50
Eps Basic Q1 2025 · Mar 31, 2024 −$0.50
Sga Expense Q1 2025 · Mar 31, 2024 $85.77M
Net Income Q1 2025 · Mar 31, 2024 −$59.95M
Operating Income Q1 2025 · Mar 31, 2024 −$61.5M
Gross Profit Q1 2025 · Mar 31, 2024 $92.91M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $48.09M
Revenue Q1 2025 · Mar 31, 2024 $141.01M